Results 21 to 30 of about 1,416 (129)

Estudio del efecto del tratamiento con inmunoglobulinas por vía intravenosa en la neuromielitis óptica

Neurología, 2013
Resumen: Objetivo: Evaluar la seguridad y tolerancia de las inmunoglobulinas por vía intravenosa (IgIV) para el tratamiento de la neuromielitis óptica (NMO).
M.J. Magraner, F. Coret, B. Casanova
doaj   +1 more source

Fertility preferences and unmet need for family planning in women with multiple sclerosis

Frontiers in Neurology, 2022
BackgroundMost women with multiple sclerosis (MS) have childbearing potential. Although fertility and pregnancy are not affected by MS, the fertility preferences of women with MS can change due to the risk of complications for the mother and/or adverse ...
Lorena López-Reyes, Lorena López-Reyes, Claudia Guío-Sánchez, Catalina González-Uribe, Simón Cárdenas-Robledo, Simón Cárdenas-Robledo   +5 more
doaj   +1 more source

The effect of intravenous immunoglobulin on neuromyelitis optica

Neurología (English Edition), 2013
Objective: Evaluate safety and tolerance levels for intravenous immunoglobulins (IVIG) as treatment for neuromyelitis optica (NMO). Methods: Eight patients meeting Wingerchuk's revised diagnostic criteria were treated with IVIG every 2 months (0.7 g/kg ...
M.J. Magraner, F. Coret, B. Casanova
doaj   +1 more source

Recommendations for the clinical use of motor evoked potentials in multiple sclerosis

Neurología (English Edition), 2013
Objective: To establish clinical guidelines for the clinical use and interpretation of motor evoked potentials (MEP) in diagnosing and monitoring patients with multiple sclerosis (MS).
V. Fernández, J. Valls-Sole, J.L. Relova, N. Raguer, F. Miralles, L. Dinca, S. Taramundi, L. Costa-Frossard, M. Ferrandiz, Ll. Ramió-Torrentà, P. Villoslada, A. Saiz, C. Calles, A. Antigüedad, J.C. Alvarez-Cermeño, J.M. Prieto, G. Izquierdo, X. Montalbán, O. Fernández   +18 more
doaj   +1 more source

Recomendaciones para la utilización clínica del estudio de potenciales evocados motores en la esclerosis múltiple

Neurología, 2013
Resumen: Objetivo: Establecer una guía clínica para la utilización clínica del estudio de potenciales evocados motores (PEM) en el diagnóstico y el seguimiento de la esclerosis múltiple (EM).
V. Fernández, J. Valls-Sole, J.L. Relova, N. Raguer, F. Miralles, L. Dinca, S. Taramundi, L. Costa-Frossard, M. Ferrandiz, Ll. Ramió-Torrentà, P. Villoslada, A. Saiz, C. Calles, A. Antigüedad, J.C. Alvarez-Cermeño, J.M. Prieto, G. Izquierdo, X. Montalbán, O. Fernández   +18 more
doaj   +1 more source

Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

Vaccines, 2023
This single-center study included 68 multiple sclerosis (MS) patients who received the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination from one of several approved vaccine preparations in Spain.
Alexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Enric Monreal, Paulette Esperanza Walo-Delgado, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, Rafael Rodríguez-Ramos, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar   +11 more
doaj   +1 more source

A Polymorphism Within the MBP Gene Is Associated With a Higher Relapse Number in Male Patients of Multiple Sclerosis

Frontiers in Immunology, 2020
Myelin basic protein (MBP) is thought to be one of the key autoantigens in multiple sclerosis (MS) development. A recent study described the association of the single nucleotide polymorphism (SNP) rs12959006, within the MBP gene, with a higher risk of ...
Laura Espino-Paisán, Teresa Agudo-Jiménez, Isabel Rosales-Martínez, Pilar López-Cotarelo, María Ángel García-Martínez, María Inmaculada Domínguez-Mozo, Silvia Pérez-Pérez, Romina Dieli-Crimi, Manuel Comabella, Elena Urcelay, Roberto Álvarez-Lafuente   +10 more
doaj   +1 more source

Natalizumab for relapsing-remitting multiple sclerosis

Neurología (English Edition), 2011
Introduction: Natalizumab is a monoclonal antibody that inhibits leukocyte migration across the blood-brain barrier and has been approved for the treatment of relapsing-remitting multiple sclerosis.
A. Horga, M. Tintoré
doaj   +1 more source

Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls

Cells, 2021
Although the etiology of multiple sclerosis (MS) is still unknown, it is commonly accepted that environmental factors could contribute to the disease.
Maria Inmaculada Dominguez-Mozo, Silvia Perez-Perez, Noelia Villarrubia, Lucienne Costa-Frossard, Jose Ignacio Fernandez-Velasco, Isabel Ortega-Madueño, Maria Angel Garcia-Martinez, Estefania Garcia-Calvo, Hector Estevez, Jose Luis Luque Garcia, Maria Josefa Torrejon, Rafael Arroyo, Luisa Maria Villar, Roberto Alvarez-Lafuente   +13 more
doaj   +1 more source

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis

Frontiers in Immunology, 2019
Gut microbiota dysbiosis has been implicated in MS and other immune diseases, although it remains unclear how manipulating the gut microbiota may affect the disease course.
Leyre Mestre, Leyre Mestre, Francisco Javier Carrillo-Salinas, Miriam Mecha, Miriam Mecha, Ana Feliú, Ana Feliú, Carmen Espejo, Carmen Espejo, Carmen Espejo, José Carlos Álvarez-Cermeño, José Carlos Álvarez-Cermeño, Luisa María Villar, Luisa María Villar, Carmen Guaza, Carmen Guaza   +15 more
doaj   +1 more source